Description
The Department of Veterans Affairs is seeking information from potential vendors for the provision of high input, automated Chemiluminescent Immunoassay (CLIA) testing for CMV, Lyme, Measles, Mumps, Rubella, and VZV at the VA Pittsburgh Healthcare System and the Philadelphia VA Medical Center. Interested parties must have an active registration in the System for Award Management (SAM) database and must submit a capability statement, relevant literature, and a point of contact name, phone number, and email address. The notice also includes questions regarding the firm's socio-economic status, such as whether it is a small business, veteran-owned, or service-disabled veteran-owned.
• The testing must be completed at the specified locations in Pittsburgh and Philadelphia, PA.
• The notice is not a solicitation document, but the government reserves the right to solicit bids or proposals at a later date.
• Responses to the notice are required by February 11th, 2022, at 4:00 pm EST.
• Questions regarding the notice should be addressed to Keri Hester via email only.
Attached files
Contact
Keri Hester(Contracting Officer)